Keyphrases
Long-term Survival
100%
Patient Survival
100%
Metastatic Non-small Cell Lung Cancer
100%
Five Decades
100%
Adenocarcinoma
50%
Non-small Cell Lung Cancer Patients
50%
Clinical Trials
25%
Novel Therapeutics
25%
Chemotherapy
25%
Improved Outcomes
25%
Supportive Care
25%
Epidemiology
25%
Young Female
25%
Combination Chemotherapy
25%
Fold Increase
25%
Long-term Survivors
25%
High-income
25%
Kaplan-Meier
25%
Mutant Protein
25%
Proportional Hazards Model
25%
5-year Survival
25%
Absolute Count
25%
Survival Statistics
25%
Recent Diagnosis
25%
End Results Database
25%
Therapeutic Care
25%
Asian Pacific Islander
25%
Small Molecule Targeting
25%
Medicine and Dentistry
Long Term Survival
100%
Non Small Cell Lung Cancer
100%
Adenocarcinoma
66%
Proportional Hazards Model
33%
Supportive Care
33%
Clinical Trial
33%
Epidermal Growth Factor Receptor
33%
Combination Chemotherapy
33%
Population Research
33%
Cohort Effect
33%
Immunotherapy
33%
Mutant Protein
33%
Asian Pacific Islanders
33%
Pharmacology, Toxicology and Pharmaceutical Science
Long Term Survival
100%
Non Small Cell Lung Cancer
100%
Chemotherapy
66%
Adenocarcinoma
66%
Clinical Trial
33%
Population Study
33%
Immunotherapy
33%
Epidermal Growth Factor Receptor
33%
Mutant Protein
33%
Biochemistry, Genetics and Molecular Biology
Long Term Survival
100%
Population Research
33%
Clinical Trial
33%
Epidermal Growth Factor Receptor
33%
Small Molecule
33%
Mutant Protein
33%
Agricultural and Biological Sciences
Epidermal Growth Factor Receptor
100%
Pacific Islanders
100%